STOP DIABETES - Knowledge-based Solutions

NCT03156478 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2017-05-17

No results posted yet for this study

Summary

The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test approaches to identify individuals at increased risk of type 2 diabetes and to empower them in adopting and maintaining a healthy lifestyle by combining individual and environment level strategies into a dual-process approach targeting deliberative and automatic processes of behavior. We also aim to identify barriers and facilitators of adopting a healthy lifestyle in the society, create a model for the prevention of type 2 diabetes by joint actions of health care, third sector, and other societal actors, and develop methods to monitor the cost-effectiveness of these actions. We will carry out a 1-year randomized controlled trial on the effects of among 10 000 individuals aged 18-70 years at increased risk of type 2 diabetes living in Finland. The participants will be randomized into the control group, the digital lifestyle intervention group, or the combined digital and face-to-face lifestyle intervention group. The aim of the interventions is to enhance diet quality, increase physical activity, decrease body weight, and improve glucose tolerance in individuals at increased risk of type 2 diabetes.

Conditions

  • Type2 Diabetes
  • Life Style
  • Diet Habit
  • Physical Activity
  • Empowerment

Interventions

BEHAVIORAL

Digital lifestyle intervention group

Intervention with digital application for lifestyle changes

BEHAVIORAL

Combined digital and face-to-face lifestyle intervention group

Intervention with digital application and group meetings for lifestyle changes

Sponsors & Collaborators

  • National Institute of Health and Welfare

    collaborator UNKNOWN
  • Technical Research Centre of Finland

    collaborator UNKNOWN
  • University of Melbourne

    collaborator OTHER
  • University of Konstanz

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Maastricht University

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Danube-University

    collaborator UNKNOWN
  • Flinders University

    collaborator OTHER
  • Cornell University

    collaborator OTHER
  • University of Copenhagen

    collaborator OTHER
  • Roskilde University

    collaborator OTHER
  • University of Manchester

    collaborator OTHER
  • University of York

    collaborator OTHER
  • University of Eastern Finland

    lead OTHER

Principal Investigators

  • Jussi Pihlajamäki, MD, PhD · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2018-12-31
Completion
2037-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03156478 on ClinicalTrials.gov